The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults (scientific article)

cites work (P2860)

Q92988019	"Will you treat me? I'm suicidal!" The effect of patient gender, suicidal severity, and therapist characteristics on the therapist's likelihood to treat a hypothetical suicidal patient
Q94070142	"Zero Suicide" - A model for reducing suicide in United States behavioral healthcare
Q58104849	3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
Q88573326	3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
Q89136877	A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults
Q42697087	A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders
Q37610768	A Breathing-Based Meditation Intervention for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study
Q55129707	A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.
Q45953775	A Controlled Trial Using Natural Language Processing to Examine the Language of Suicidal Adolescents in the Emergency Department.
Q50127136	A Controlled Trial of Extended-Release Guanfacine and Psychostimulants on Executive Function and ADHD.
Q37580733	A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders
Q92150502	A History of Trauma is Associated with Aggression, Depression, Non-Suicidal Self-Injury Behavior, and Suicide Ideation in First-Episode Psychosis
Q64238308	A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
Q30275691	A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence
Q93062230	A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and
Q53414630	A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.
Q33590913	A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder
Q36967796	A Pilot Study of Safety and Efficacy of Cranial Electrotherapy Stimulation in Treatment of Bipolar II Depression
Q48066356	A Preliminary Test of the Interpersonal Psychological Theory of Suicidal Behavior in Young People With a First Episode of Psychosis
Q92582730	A Randomized Clinical Trial of Atomoxetine for Mild Cognitive Impairment in Parkinson's Disease
Q47172695	A Randomized Trial of Lorcaserin and Lifestyle Counseling for Maintaining Weight Loss Achieved with a Low-Calorie Diet
Q47579231	A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia
Q39739858	A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients with Chronic Low Back Pain
Q92976664	A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Set
Q47710967	A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder
Q37651165	A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder
Q38713789	A Risk Algorithm for the Persistence of Suicidal Thoughts and Behaviors During College
Q34502250	A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies
Q38386828	A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder
Q92863469	A Systematic Review of the Evidence Supporting Mobile- and Internet-Based Psychological Interventions For Self-Harm
Q49946065	A Test of Multi-Session Automatic Action Tendency Retraining to Reduce Alcohol Consumption among Young Adults in the Context of a Human Laboratory Paradigm.
Q33735078	A brief psychological intervention to reduce repetition of self-harm in patients admitted to hospital following a suicide attempt: a randomised controlled trial
Q38952459	A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).
Q38879785	A conceptual model for generating and validating in-session clinical judgments.
Q60532518	A data mining approach of electronic health EHR data for suicide risk management : towards clinical decision support systems (CDSS) in suicide prevention. (Preprint)
Q33632732	A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder
Q92784704	A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder
Q36475355	A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia
Q36366194	A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder
Q50132603	A long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
Q94959492	A long-term, open-label study of valbenazine for tardive dyskinesia
Q93129081	A minimum evaluation protocol and stepped-wedge cluster randomized trial of ACCESS Open Minds, a large Canadian youth mental health services transformation project
Q28083953	A multidisciplinary approach to therapeutic risk management of the suicidal patient
Q42714851	A novel V1a receptor antagonist blocks vasopressin-induced changes in the CNS response to emotional stimuli: an fMRI study
Q35807939	A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers
Q58560796	A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Q24564427	A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran extended-release in patients with major depressive disorder
Q47861374	A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
Q48386112	A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder
Q91490286	A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder
Q38374699	A randomized controlled trial of ganaxolone in posttraumatic stress disorder
Q43105420	A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet
Q34322964	A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia.
Q96765366	A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Q35607556	A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD.
Q55398104	A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis.
Q35986975	A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
Q37077152	A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder
Q38177733	A theory-based approach to understanding suicide risk in shelter-seeking women
Q58587698	A visual analog scale to measure psychological and physical pain: A preliminary validation of the PPP-VAS in two independent samples of depressed patients
Q37346136	ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension
Q89611766	Abrupt withdrawal of cannabidiol (CBD): A randomized trial
Q36044477	Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects
Q52564915	Accelerated Outpatient Individual Cognitive Behavioural Therapy for Social Anxiety Disorder: A Preliminary Pilot Study.
Q93122487	Accuracy of online survey assessment of mental disorders and suicidal thoughts and behaviors in Spanish university students. Results of the WHO World Mental Health- International College Student initiative
Q61443643	Active contact and follow-up interventions to prevent repeat suicide attempts during high-risk periods among patients admitted to emergency departments for suicidal behavior: a systematic review and meta-analysis
Q47651730	Active suicidal ideation during clinical antidepressant trials
Q37048036	Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study
Q90436208	Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open-label, long-term safety and tolerability study
Q37339751	Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
Q34614505	Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study
Q47589877	Adverse reaction with suvorexant for insomnia: acute worsening of depression with emergence of suicidal thoughts
Q57286724	Aerobic exercise program with or without motor complexity as an add-on to the pharmacological treatment of depression - study protocol for a randomized controlled trial
Q90733606	Affect-Focused Psychodynamic Internet-Based Therapy for Adolescent Depression: Randomized Controlled Trial
Q39147996	Affective lability mediates the association between childhood trauma and suicide attempts, mixed episodes and co-morbid anxiety disorders in bipolar disorders
Q90915562	Agreement between self and psychiatrist reporting of suicidal ideation at a Veterans Administration psychiatric emergency clinic
Q39156643	Alcohol Misuse and Co-Occurring Mental Disorders Among New Soldiers in the U.S. Army
Q88656907	Altered Cortical GABA in Female Veterans with Suicidal Behavior: Sex Differences and Clinical Correlates
Q93195718	Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation
Q92543622	Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
Q89504413	An Interactive Web-Based Lethal Means Safety Decision Aid for Suicidal Adults (Lock to Live): Pilot Randomized Controlled Trial
Q89926194	An Open-Label, Randomized Bioavailability Study of Alternative Methods of Oral Administration of Naloxegol in Healthy Subjects
Q35602627	An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women
Q51741053	An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia.
Q38044018	An update on antidepressant use and suicidality in pediatric depression
Q57169417	Anhedonia and suicidal thoughts and behaviors in psychiatric outpatients: The role of acuity
Q47642434	Antidepressant-induced activation in children and adolescents: Risk, recognition and management
Q38045012	Antiepileptic drugs and suicidality: an expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology
Q64864651	Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Q39560283	Are there gender-specific risk factors for suicidal activity among patients with schizophrenia and depression?
Q90318248	As Safe as Possible (ASAP): A Brief App-Supported Inpatient Intervention to Prevent Postdischarge Suicidal Behavior in Hospitalized, Suicidal Adolescents
Q47783378	Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review
Q53538328	Asian Women's Action for Resilience and Empowerment Intervention: Stage I Pilot Study.
Q35992986	Assessing Suicidal Ideation and Behaviors Among Survivors of Childhood Brain Tumors and Their Mothers During Sociobehavioral Research.
Q35908061	Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
Q92555699	Assessing recent suicidal ideation and behavior in the adult epilepsy monitoring unit
Q35689143	Assessing suicidal ideation in individuals at clinical high risk for psychosis
Q36276009	Assessing the risk for suicide in schizophrenia according to migration, ethnicity and geographical ancestry
Q91583035	Assessment and Management of Suicide Risk in Children and Adolescents
Q45928184	Assessment and management of suicide risk in primary care.
Q57700286	Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)
Q64088068	Assessment of a Risk Index for Suicide Attempts Among US Army Soldiers With Suicide Ideation: Analysis of Data From the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)
Q33739163	Assessment of psychological pain in suicidal veterans
Q39110993	Assessment of suicidal youth in the emergency department
Q90425073	Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis
Q53408821	Association between Perceived Stressfulness of Stressful Life Events and the Suicidal Risk in Chinese Patients with Major Depressive Disorder.
Q89286668	Association between clinical observations and a mobile crisis team's level of care recommendations
Q64075407	Association of Suicide Risk With Headache Frequency Among Migraine Patients With and Without Aura
Q100507156	Associations of Discrimination, Suicide Ideation Severity and Attempts, and Depressive Symptoms Among Sexual and Gender Minority Youth
Q38859069	Associations of childhood bullying victimization with lifetime suicidal behaviors among new U.S. Army soldiers
Q47843632	Associations of suicidality with cognitive ability and cognitive insight in outpatients with Schizophrenia
Q55074354	Attachment to Parents As a Moderator in the Association between Sibling Bullying and Depression or Suicidal Ideation among Children and Adolescents.
Q93263637	Attention Deficit Hyperactivity Disorder and Risk of Posttraumatic Stress and Related Disorders: A Prospective Longitudinal Evaluation in U.S. Army Soldiers
Q34442413	Attention benefits after a single dose of metadoxine extended release in adults with predominantly inattentive ADHD.
Q92985161	Attentional bias modification treatment for depression: Study protocol for a randomized controlled trial
Q35495409	Attitudes of acceptability and lack of condemnation toward suicide may be predictive of post-discharge suicide attempts
Q59754858	Augmenting Buried in Treasures with in-home uncluttering practice: Pilot study in hoarding disorder
Q61807672	Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: study protocol for a single-blind parallel-group randomised controlled trial (THRIVE)
Q92964198	Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)
Q48086572	BDNF promoter methylation associated with suicidal ideation in patients with breast cancer
Q91874380	Barriers of mental health treatment utilization among first-year college students: First cross-national results from the WHO World Mental Health International College Student Initiative
Q90054288	Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression
Q58588941	Behavioral and cognitive intervention strategies delivered via coached apps for depression: Pilot trial
Q38820987	Between-visit changes in suicidal ideation and risk of subsequent suicide attempt
Q38764318	Blunted HPA axis activity prior to suicide attempt and increased inflammation in attempters.
Q94502541	Borderline Personality Disorder With Depression Confers Significant Risk of Suicidal Behavior in Mood Disorder Patients-A Comparative Study
Q59812103	Borderline personality disorder in adolescents: prevalence, diagnosis, and treatment strategies
Q94496574	Brain function and clinical characterization in the Boston adolescent neuroimaging of depression and anxiety study
Q47720087	Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Q91274876	Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Q39009497	Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
Q26766401	Brexpiprazole: so far so good
Q45951919	Can integrating the Memory Support Intervention into cognitive therapy improve depression outcome? Study protocol for a randomized controlled trial.
Q47316111	Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders
Q37197211	Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care
Q56516339	Cancer and suicidal ideation and behaviours: protocol for a systematic review and meta-analysis
Q98194461	Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy
Q64954388	Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
Q90431838	Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies
Q47717136	Cebranopadol, a novel first-in-class analgesic drug candidate: first experience in patients with chronic low back pain in a randomized clinical trial
Q92268464	Cerebral bioenergetic differences measured by phosphorus-31 magnetic resonance spectroscopy between bipolar disorder and healthy subjects living in two different regions suggesting possible effects of altitude
Q64118254	Challenges of Population-based Measurement of Suicide Prevention Activities Across Multiple Health Systems
Q47322489	Change in Experiential Avoidance is Associated with Reduced Suicidal Ideation over the Course of Psychiatric Hospitalization
Q33583693	Change in suicidal ideation after interdisciplinary treatment of chronic pain
Q91714230	Changes in typical beliefs in response to complicated grief treatment
Q53695986	Characteristics of the suicidal soldier in the Israeli Defense Force-a review of literature.
Q38757127	Child Psychiatric Emergencies: Updates on Trends, Clinical Care, and Practice Challenges
Q37402204	Child abuse and the prevalence of suicide attempts among those reporting suicide ideation.
Q47735605	Child- and Family-Focused Cognitive Behavioral Therapy for Pediatric Bipolar Disorder: Applications for Suicide Prevention.
Q30370127	Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: a randomized clinical trial
Q38765369	Childhood Maltreatment and Lifetime Suicidal Behaviors Among New Soldiers in the US Army: Results From the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q52589231	Children and Young People-Mental Health Safety Assessment Tool (CYP-MH SAT) study: Protocol for the development and psychometric evaluation of an assessment tool to identify immediate risk of self-harm and suicide in children and young people (10-19
Q45056844	Clarifying the role of neuroticism in suicidal ideation and suicide attempt among women with major depressive disorder
Q33767175	Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations
Q42372610	Classification of Suicide Attempts through a Machine Learning Algorithm Based on Multiple Systemic Psychiatric Scales
Q95642195	Clinical Trials and Tribulations in the COVID-19 Era
Q38639281	Clinical correlates of symptom severity in skin picking disorder
Q40149785	Clinical features, impulsivity, temperament and functioning and their role in suicidality in patients with bipolar disorder
Q46467522	Clinician Prediction of Future Suicide Attempts: A Longitudinal Study
Q60047653	Cognitive and Functional Assessment of Psychosis Stratification Study (CoFAPSS): Rationale, Design, and Characteristics
Q34647271	Cognitive and family correlates of current suicidal ideation in children with bipolar disorder.
Q30837059	Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled sup
Q38763149	Cognitive-Behavioral Family Treatment for Suicide Attempt Prevention: A Randomized Controlled Trial
Q47276941	Cohort Profile: The Heinz C. Prechter Longitudinal Study of Bipolar Disorder
Q37285965	Columbia-suicide severity rating scale: predictive validity with adolescent psychiatric emergency patients
Q38822654	Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial
Q39182453	Combination Varenicline and Lorcaserin for Tobacco Dependence Treatment and Weight Gain Prevention in Overweight and Obese Smokers: A Pilot Study
Q57796045	Combining brief contact interventions (BCI) into a decision-making algorithm to reduce suicide reattempt: the VigilanS study protocol
Q93167761	Combining mobile-health (mHealth) and artificial intelligence (AI) methods to avoid suicide attempts: the Smartcrises study protocol
Q35786164	Combining the Suicide Intent Scale and the Karolinska Interpersonal Violence Scale in suicide risk assessments
Q57063764	Community Study of Outcome Monitoring for Emotional Disorders in Teens (COMET): A comparative effectiveness trial of a transdiagnostic treatment and a measurement feedback system
Q41847567	Comparative Validation of the S-STS, the ISST-Plus, and the C-SSRS for Assessing the Suicidal Thinking and Behavior FDA 2012 Suicidality Categories
Q57193576	Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial
Q54254630	Comparing dedicated and designated models of integrating mental health into chronic disease care: study protocol for a cluster randomized controlled trial.
Q44136231	Complicated grief after suicide bereavement and other causes of death
Q35124735	Computer-assisted cognitive behavior therapy for obsessive-compulsive disorder: a randomized trial on the impact of lay vs. professional coaching
Q64136405	Connectedness to family, school, peers, and community in socially vulnerable adolescents
Q47281163	Connecting Eating Pathology with Risk for Engaging in Suicidal Behavior: The Mediating Role of Experiential Avoidance
Q42689711	Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia
Q39573547	Considerations in the Use of Interactive Voice Recording for the Temporal Assessment of Suicidal Ideation and Alcohol Use.
Q38686107	Contributions of Cognitions, Psychological Flexibility, and Therapeutic Alliance to Suicidal Ideation in Psychiatric Inpatients
Q35135611	Coping skills among adolescent suicide attempters: results of a multisite study
Q35135624	Coping strategies associated with suicidal behaviour in adolescent inpatients with borderline personality disorder
Q44801363	Correlates of suicide stigma and suicide literacy in the community.
Q88498642	Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents
Q36402210	Creating a Chinese suicide dictionary for identifying suicide risk on social media
Q37162027	Culturally Grounded Stress Reduction and Suicide Prevention for African American Adolescents.
Q34713042	Current Assessment and Classification of Suicidal Phenomena using the FDA 2012 Draft Guidance Document on Suicide Assessment: A Critical Review
Q34475309	Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
Q53447300	Decreased suicide rates in recent antidepressant clinical trials.
Q30587237	Deep brain stimulation of the basolateral amygdala for treatment-refractory combat post-traumatic stress disorder (PTSD): study protocol for a pilot randomized controlled trial with blinded, staggered onset of stimulation
Q37071991	Deep brain stimulation of the ventral striatum/anterior limb of the internal capsule in thalamic pain syndrome: study protocol for a pilot randomized controlled trial
Q100490885	Deep neural networks detect suicide risk from textual facebook posts
Q92393803	Default mode dysfunction underpins suicidal activity in mood disorders
Q36265563	Delusional Disorder over the Reproductive Life Span: The Potential Influence of Menopause on the Clinical Course.
Q93140777	Demographic and Clinical Characteristics of Military Service Members Hospitalized Following a Suicide Attempt versus Suicide Ideation
Q33852571	Demographic and clinical characteristics of consistent and inconsistent longitudinal reporters of lifetime suicide attempts in adolescence through young adulthood
Q90373351	Depression Screening in Pediatric Inflammatory Bowel Disease Clinics: Recommendations and a Toolkit for Implementation
Q92037621	Depression and suicidal ideation in high-performance athletes suffering from low back pain: The role of stress and pain-related thought suppression
Q39417482	Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
Q64094974	Depression, Suicidal Ideation, and Resilience among Rural Drought-Affected Farmers: Methodological Issues
Q88238530	Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups
Q48046819	Describing and Measuring the Pathway to Suicide Attempts: A Preliminary Study
Q37037316	Descriptive and Psychometric Properties of the Inventory of Motivations for Suicide Attempts (IMSA) in an Inpatient Adolescent Sample
Q47692217	Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder
Q47693093	Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
Q95650280	Detecting suicidal thoughts: The power of ecological momentary assessment
Q43814918	Determinants of suicidal ideation in patients with breast cancer
Q92252601	Developing an optimal short-form of the PTSD Checklist for DSM-5 (PCL-5)
Q45050121	Development and feasibility of the misuse, abuse, and diversion drug event reporting system (MADDERS®).
Q58085228	Development and pilot study of a suicide prevention intervention delivered by peer support specialists
Q64039389	Development and psychometric properties of the "Suicidality: Treatment Occurring in Paediatrics (STOP) Risk and Resilience Factors Scales" in adolescents
Q36222646	Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents
Q64097557	Development and validation of Yatt Suicide Attitude Scale (YSAS) in Malaysia
Q62722207	Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress
Q36165968	Development of practice principles for the management of ongoing suicidal ideation in young people diagnosed with major depressive disorder
Q47318626	Development of the Suicide Risk Scale for Medical Inpatients.
Q34911802	Difference in suicide methods used between suicide attempters and suicide completers
Q37136972	Differences between Impulsive and Non-Impulsive Suicide Attempts among Individuals Treated in Emergency Rooms of South Korea
Q91981225	Differences in Suicide Risk Severity Among Suicidal Youth With Anxiety Disorders
Q91617735	Diminished responses to bodily threat and blunted interoception in suicide attempters
Q40161338	Disentangling depression and anxiety in relation to neuroticism, extraversion, suicide, and self-harm among adult psychiatric inpatients with serious mental illness
Q47325786	Dissociation and acquired capability as facilitators of suicide ideation among soldiers
Q34712940	Do the Five Combinations of Suicidal Ideation in the FDA 2012 Draft Guidance Document and the C-SSRS Adequately Cover All Suicidal Ideation Combinations in Practice? A Case Study
Q35634557	Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode.
Q33861162	Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death?
Q93200965	Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia
Q91618237	Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder
Q89964557	Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
Q38398854	EVALUATING POTENTIAL IATROGENIC SUICIDE RISK IN TRAUMA-FOCUSED GROUP COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF PTSD IN ACTIVE DUTY MILITARY PERSONNEL.
Q38916210	Early Childhood Environment and Genetic Interactions: the Diathesis for Suicidal Behavior
Q92861755	Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss - results of an exploratory study
Q90382025	Ecological assessment of daily suicidal thoughts and attempts among suicidal teens after psychiatric hospitalization: Lessons about feasibility and acceptability
Q57299960	Ecologically assessed affect and suicidal ideation following psychiatric inpatient hospitalization
Q47557467	Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials
Q37009115	Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
Q64946020	Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial.
Q48042619	Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial
Q92147173	Effect of a Motivational Interviewing-Based Intervention on Initiation of Mental Health Treatment and Mental Health After an Emergency Department Visit Among Suicidal Adolescents: A Randomized Clinical Trial
Q93029762	Effect of a Virtual Patient Navigation Program on Behavioral Health Admissions in the Emergency Department: A Randomized Clinical Trial
Q51334594	Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies.
Q48325315	Effect of hepatic impairment on the pharmacokinetics of levomilnacipran following a single oral dose of a levomilnacipran extended-release capsule in human participants
Q64066798	Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial
Q99248380	Effectiveness and moderators of individual cognitive behavioral therapy versus treatment as usual in clinically depressed adolescents: a randomized controlled trial
Q49996642	Effectiveness of a Web-Based Self-Help Program for Suicidal Thinking in an Australian Community Sample: Randomized Controlled Trial.
Q58768483	Effectiveness of iconic therapy for the reduction of borderline personality disorder symptoms among suicidal youth: study protocol for a randomised controlled trial
Q61805890	Effectiveness of interventions for people bereaved through suicide: a systematic review of controlled studies of grief, psychosocial and suicide-related outcomes
Q34073723	Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
Q35844491	Effectiveness of the first French psychoeducational program on unipolar depression: study protocol for a randomized controlled trial.
Q91671233	Effects of Roflumilast on Rehospitalization and Mortality in Patients
Q58568782	Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
Q30491758	Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials
Q46070769	Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
Q33625354	Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
Q95315322	Efficacy and Safety of Dasotraline in Adults with Binge-Eating Disorder: A Randomized, Placebo-controlled, Fixed-dose Clinical Trial
Q92492120	Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial
Q41495591	Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
Q42339253	Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study
Q38376209	Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
Q92649371	Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial
Q34853281	Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial
Q34063590	Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial
Q34393030	Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder
Q92076787	Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial
Q37511619	Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.
Q35038928	Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial
Q47716057	Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study
Q26824097	Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis
Q57407760	Efficacy of Acceptance and Commitment Therapy in Reducing Suicidal Ideation and Deliberate Self-Harm: Systematic Review
Q38374118	Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial
Q35588067	Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study
Q59128324	Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
Q46598908	Efficacy of smoking cessation therapy alone or integrated with prolonged exposure therapy for smokers with PTSD: Study protocol for a randomized controlled trial
Q37667633	Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting
Q35576952	Electronic protocol for suicide risk management in research participants
Q38965291	Emergency Department Screening for Suicide and Mental Health Risk
Q34425274	Emergency room validation of the revised Suicide Trigger Scale (STS-3): a measure of a hypothesized suicide trigger state
Q89104983	Emerging trends in adolescent suicide prevention research
Q42376746	Emotion regulation group therapy for deliberate self-harm: a multi-site evaluation in routine care using an uncontrolled open trial design
Q64119298	Emotional Pain Mediates the Link Between Preoccupied Attachment and Non-suicidal Self-Injury in High Suicide Risk Psychiatric Inpatients
Q53406299	Emotional Responses to Suicidal Patients: Factor Structure, Construct, and Predictive Validity of the Therapist Response Questionnaire-Suicide Form.
Q47283803	Emotional face recognition in adolescent suicide attempters and adolescents engaging in non-suicidal self-injury
Q37283113	Emotional suppression mediates the relation between adverse life events and adolescent suicide: implications for prevention
Q91750632	Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience (EMPOWER) among Surrogate Decision-Makers of ICU Patients: study protocol for a randomized controlled trial
Q37187619	Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial
Q38661992	Establishing Measurement-based Care in Integrated Primary Care: Monitoring Clinical Outcomes Over Time
Q60491417	Evaluating the Feasibility and Effectiveness of an Australian Safety Planning Smartphone Application: A Pilot Study Within a Tertiary Mental Health Service
Q92661610	Evaluation of A Suicide Prevention Program in Switzerland: Protocol of A Cluster Non-Randomized Controlled Trial
Q92511796	Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL-1 to Healthy Volunteers
Q89714970	Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
Q34454397	Evaluation of opioid modulation in major depressive disorder
Q90936188	Evaluation of the Pharmacokinetic Interaction Between the Voltage- and Use-Dependent Nav1.7 Channel Blocker Vixotrigine and Carbamazepine in Healthy Volunteers
Q92559991	Evaluation of the Teaching Recovery Techniques community-based intervention for unaccompanied refugee youth experiencing post-traumatic stress symptoms (Swedish UnaccomPanied yOuth Refugee Trial; SUPpORT): study protocol for a randomised controlled
Q47733836	Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study
Q33819692	Evidence for the management of adolescent depression.
Q47608461	Examining the characteristics and clinical features of in- and between-session suicide risk assessments among psychiatric outpatients.
Q57048095	Exploring Cross-Sectional Predictors of Suicide Ideation, Attempt, and Risk in a Large Online Sample of Transgender and Gender Nonconforming Youth and Young Adults
Q41283976	Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study
Q38381196	Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial
Q36844282	Facial trust appraisal negatively biased in borderline personality disorder
Q42388909	Facilitating Action for Suicide Prevention by Learning Health Care Systems
Q37405804	Factors Associated With Suicide Outcomes 12 Months After Screening Positive for Suicide Risk in the Emergency Department
Q52316131	Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
Q35569521	Familial pathways to early-onset suicide attempt: a 5.6-year prospective study
Q47651600	Feasibility and Preliminary Efficacy of Tailored Yoga in Survivors of Head and Neck Cancer: A Pilot Study.
Q30835050	Feasibility and Preliminary Efficacy of a Novel RDoC-Based Treatment Program for Adolescent Depression: "Training for Awareness Resilience and Action" (TARA)-A Pilot Study
Q61443889	Feasibility of a randomised controlled trial of remotely delivered problem-solving cognitive behaviour therapy versus usual care for young people with depression and repeat self-harm: lessons learnt (e-DASH)
Q91875829	Feasibility, preliminary efficacy, and safety of a randomized clinical trial for Asian Women's Action for Resilience and Empowerment (AWARE) intervention
Q35026679	Free, brief, and validated: Standardized instruments for low-resource mental health settings
Q47278694	Frequency and Methods of Nonsuicidal Self-Injury in Relation to Acquired Capability for Suicide Among Adolescents
Q46548879	Frontal Motor Cortex Activity During Reactive Control Is Associated With Past Suicidal Behavior in Recent-Onset Schizophrenia
Q34335917	Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
Q38855838	Functional domains as correlates of suicidality among psychiatric inpatients
Q92457899	Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease
Q27025974	GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists
Q47737250	GWAS analysis of treatment resistant schizophrenia: interaction effect of childhood trauma
Q58591817	Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial assessing Efficacy and Safety
Q60960553	Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study
Q34258814	Gender-specific effects of depression and suicidal ideation in prosocial behaviors.
Q41522950	General Anesthesia versus Local Anesthesia in StereotaXY (GALAXY) for Parkinson's disease: study protocol for a randomized controlled trial
Q61447368	Genetic associations with suicide attempt severity and genetic overlap with major depression
Q47159397	Genetic predisposition toward suicidal ideation in patients with acute coronary syndrome
Q56069696	Genetics of dementia
Q46423585	Genomewide association studies of suicide attempts in US soldiers
Q98779325	Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †
Q91107579	Gratitude diary for the management of suicidal inpatients: A randomized controlled trial
Q89641814	Group ("Project Life Force") versus individual suicide safety planning: A randomized clinical trial
Q99637367	Guided Internet-delivered cognitive behaviour therapy for perfectionism in a non-clinical sample of adolescents: A study protocol for a randomised controlled trial
Q37543316	Headache Disability, Suicidality and Pain Catastrophization - Are They Related
Q33633081	Health care contacts in the year before suicide death
Q99732179	High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial
Q57131700	High-frequency repetitive TMS for suicidal ideation in adolescents with depression
Q38434851	History of Lifetime suicide attempt in bipolar I disorder: its correlates and effect on illness course
Q55093508	History of Suicide Attempt Is Associated with Reduced Medial Prefrontal Cortex Activity during Emotional Decision-Making among Men with Schizophrenia: An Exploratory fMRI Study.
Q47557055	Homelessness, Mental Health and Suicidality Among LGBTQ Youth Accessing Crisis Services
Q47318561	Hopelessness as a Predictor of Suicide Ideation in Depressed Male and Female Adolescent Youth
Q37007725	Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia
Q92898324	How Neuroscience Is Informing Treatments: Ethical Issues
Q94593062	How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the
Q45340178	Identifying Risk for Suicide
Q35200232	Identifying adolescents at highly elevated risk for suicidal behavior in the emergency department
Q39061264	Impact of a Suicide-Specific Intervention within Inpatient Psychiatric Care: The Collaborative Assessment and Management of Suicidality.
Q44922308	Impact of childhood adversity on the course and suicidality of depressive disorders: the CRESCEND study
Q38686989	Impact of childhood trauma on cognitive profile in bipolar disorder.
Q36359654	Implementation and use of a crisis hotline during the treatment as usual and universal screening phases of a suicide intervention study
Q47324530	Implicit Measure of Life/Death Orientation Predicts Response of Suicidal Ideation to Treatment in Psychiatric Inpatients
Q48036801	Implicit Measures of Suicide Risk in a Military Sample
Q52654781	In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life.
Q35746660	Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder
Q100724545	Increased burden of cardiovascular risk among youth suicide attempters
Q65000489	Increased efficiency of brain connectivity networks in veterans with suicide attempts.
Q30410311	Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt
Q60450564	Increasing intentions to use mental health services among university students. Results of a pilot randomized controlled trial within the World Health Organization's World Mental Health International College Student Initiative
Q37340020	Influences on call outcomes among veteran callers to the National Veterans Crisis Line
Q39445572	Instruments for the assessment of suicide risk: A systematic review evaluating the certainty of the evidence
Q37627331	Integrated collaborative care teams to enhance service delivery to youth with mental health and substance use challenges: protocol for a pragmatic randomised controlled trial
Q93050215	Interactive effects of PTSD and substance use on suicidal ideation and behavior in military personnel: Increased risk from marijuana use
Q26785374	International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
Q104504628	International consensus on a standard set of outcome measures for child and youth anxiety, depression, obsessive-compulsive disorder, and post-traumatic stress disorder
Q38687381	Internet-Based Cognitive-Behavioral Therapy for Depression: Current Progress and Future Directions
Q41211290	Internet-based cognitive behavior therapy for major depressive disorder: A randomized controlled trial
Q64058162	Internet-based, therapist-guided, cognitive–behavioural therapy for body dysmorphic disorder with global eligibility for inclusion: an uncontrolled pilot study
Q53439652	Interpersonal beliefs related to suicide and facial emotion processing in psychotic disorders.
Q37411888	Interpersonal violence and the prediction of short-term risk of repeat suicide attempt
Q92069377	Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
Q36172325	Is Adolescent Suicidal Ideation Continuous or Categorical? A Taxometric Analysis
Q34712964	Is There Value in Asking the Question "Do you think you would be better off dead?" in Assessing Suicidality? A Case Study
Q89611763	Is the Neurological Disorders Depression Inventory-Epilepsy for Youth (NDDI-E-Y) more sensitive than a neurologist? A quality improvement project
Q38051077	Juvenile bipolar disorder and suicidality: a review of the last 10 years of literature
Q33969125	Juvenile justice girls' depressive symptoms and suicidal ideation 9 years after Multidimensional Treatment Foster Care
Q47588716	Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.
Q91304373	Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial
Q64134374	LET's CONNECT community mentorship program for youths with peer social problems: Preliminary findings from a randomized effectiveness trial
Q34515834	LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY
Q34386899	Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug-drug interaction study
Q60960555	Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
Q99371880	Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial
Q92994650	Left rostrolateral prefrontal cortex lesions reduce suicidal ideation in penetrating traumatic brain injury
Q47590020	Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
Q37404814	Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study
Q28083216	Levomilnacipran for the treatment of major depressive disorder: a review
Q59356334	LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
Q37705296	Life events: a complex role in the timing of suicidal behavior among depressed patients
Q38718005	Lifetime Suicidal Behaviors and Career Characteristics Among U.S. Army Soldiers: Results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q63433275	Lifetime and 12-month treatment for mental disorders and suicidal thoughts and behaviors among first year college students
Q36690648	Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials
Q34474219	Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study
Q91669841	Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study
Q94560359	Long-Term Safety and Durability of Effect With a Combination of Olanzapine and Samidorphan in Patients With Schizophrenia: Results From a 1-Year Open-Label Extension Study
Q92290839	Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study
Q92127731	Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study
Q37246368	Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial
Q37138382	Long-term administration of escitalopram in patients with social anxiety disorder in Japan
Q38395740	Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia
Q62842047	Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
Q90717695	Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial
Q37675302	Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment
Q93140605	Longitudinal decreases in suicidal ideation are associated with increases in salience network coherence in depressed adolescents
Q38385068	Lorcaserin for Smoking Cessation and Associated Weight Gain: A Randomized 12-Week Clinical Trial
Q34406185	Love and suicide: the structure of the Affective Intensity Rating Scale (AIRS) and its relation to suicidal behavior
Q47906817	Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life
Q91839166	MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Q94671547	Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase I trials
Q55365950	Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).
Q57653217	Management of Suicidal Risk in Emergency Departments
Q89992615	Measurement Properties of the Suicidal Behaviour Questionnaire-Revised in Autistic Adults
Q26774887	Measurement Scales of Suicidal Ideation and Attitudes: A Systematic Review Article
Q38799761	Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations
Q47882128	Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder
Q35890058	Mental Disorders, Comorbidity, and Pre-enlistment Suicidal Behavior Among New Soldiers in the U.S. Army: Results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q47608949	Mental Health in Allergic Rhinitis: Depression and Suicidal Behavior
Q60472590	Mental disorder comorbidity and suicidal thoughts and behaviors in the World Health Organization World Mental Health Surveys International College Student initiative
Q34370417	Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine
Q39060714	Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: a pilot trial
Q92655638	Mobile Health Technology Interventions for Suicide Prevention: Systematic Review
Q92571118	Modeling the Longitudinal Effects of Insight on Depression, Quality of Life and Suicidality in Schizophrenia Spectrum Disorders: Results from the FACE-SZ Cohort
Q92168500	Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program
Q55311730	Mood Regulation Focused CBT Based on Memory Reconsolidation, Reduced Suicidal Ideation and Depression in Youth in a Randomised Controlled Study.
Q64080643	Multicenter randomized controlled trial on the comparison of multi-family therapy (MFT) and systemic single-family therapy (SFT) in young patients with anorexia nervosa: study protocol of the THERAFAMBEST study
Q30934234	Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine.
Q47275184	N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study
Q34492934	NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
Q91963675	Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial
Q34523702	Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Q38848626	Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.
Q91683554	Nicotine Dependence and Pre-Enlistment Suicidal Behavior Among U.S. Army Soldiers
Q39289962	No Way Out: Entrapment as a Moderator of Suicide Ideation Among Military Personnel
Q60532526	Nomenclature and Definition of Suicidal Behavior
Q47275522	Non-Suicidal Self-Injury Elevates Suicide Risk among United States Military Personnel with Lifetime Attempted Suicide.
Q47276081	Non-Suicidal Self-Injury in Pediatric Bipolar Disorder: Clinical Correlates and Impact on Psychosocial Treatment Outcomes.
Q57801493	Non-fatal suicidal behaviour, depression and poverty among young men living in low-resource communities in South Africa
Q41423306	Non-suicidal self-injury as a predictor of active and passive suicidal ideation among Iraq/Afghanistan war veterans
Q91066818	Non-suicidal self-injury prevalence, course, and association with suicidal thoughts and behaviors in two large, representative samples of US Army soldiers
Q41662367	Nonsuicidal self-injury and suicide attempts in Iraq/Afghanistan war veterans
Q36177233	Obsessive compulsive symptoms in individuals at clinical risk for psychosis: association with depressive symptoms and suicidal ideation
Q90692213	OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo-controlled trial in adult females
Q33578483	Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
Q42699828	Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
Q38391585	Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial
Q33923629	Oxytocin-augmented social cognitive skills training in schizophrenia
Q90576886	PF-06649751 efficacy and safety in early Parkinson's disease: a randomized, placebo-controlled trial
Q92431469	PLATELET SEROTONIN AS BIOMARKER FOR ASSESSING SUICIDAL BEHAVIOUR IN PATIENTS WITH BIPOLAR I DISORDER
Q34580449	Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges
Q38656491	Parental Self-Efficacy to Support Teens During a Suicidal Crisis and Future Adolescent Emergency Department Visits and Suicide Attempts
Q39181064	Past suicidal ideation as an independent risk factor for suicide behaviours in patients with depression
Q58594248	Patterns and predictors of persistence of suicide ideation: Results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS)
Q92142496	Patterns of change in suicide ideation signal the recurrence of suicide attempts among high-risk psychiatric outpatients
Q96122107	Pediatric Consultation-Liaison Psychiatry: An Update and Review
Q47602952	Perceived Stress and Intent to Die in Young Soldiers Who Attempt Suicide
Q89880148	Perfectionism and Prospective Near-Term Suicidal Thoughts and Behaviors: The Mediation of Fear of Humiliation and Suicide Crisis Syndrome
Q42714084	Personal Recovery as a Protective Factor Against Suicide Ideation in Individuals With Schizophrenia
Q92348030	Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD
Q88995903	Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects
Q95939604	Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single-Dose and Multiple-Ascending-Dose Phase 1 Studies in Healthy Adults
Q62633604	Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies
Q52631345	Pharmacokinetics, Safety, and Tolerability of Lamotrigine Chewable/Dispersible Tablet Following Repeat-Dose Administration in Healthy Chinese Volunteers.
Q37262261	Pharmacologic Treatment of Pediatric Anxiety Disorders
Q89683632	Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment
Q90281726	Phase I trial of caudate deep brain stimulation for treatment-resistant tinnitus
Q38743165	Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder
Q48068650	Polygenic associations of neurodevelopmental genes in suicide attempt
Q90295943	Population Pharmacokinetics, Safety and Tolerability of Extended-Release Bupropion and Its Three Metabolites in Chinese Healthy Volunteers
Q39810642	Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers
Q37260485	Population-based outreach versus care as usual to prevent suicide attempt: study protocol for a randomized controlled trial
Q47321938	Positive and Negative Expectations of Hopelessness as Longitudinal Predictors of Depression, Suicidal Ideation, and Suicidal Behavior in High-Risk Adolescents.
Q89699954	Post hoc analysis of a randomised, placebo-controlled, active-reference 6-week study of brexpiprazole in acute schizophrenia
Q47147322	Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.
Q33876684	Practical issues regarding implementing a randomized clinical trial in a homeless population: strategies and lessons learned
Q39285492	Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.
Q90073241	Practitioner Review: Treatment for suicidal and self-harming adolescents - advances in suicide prevention care
Q90214715	Pre-deployment insomnia is associated with post-deployment post-traumatic stress disorder and suicidal ideation in US Army soldiers
Q56334312	Predeployment predictors of psychiatric disorder-symptoms and interpersonal violence during combat deployment
Q34585617	Predicting Future Suicide Attempts Among Adolescent and Emerging Adult Psychiatric Emergency Patients
Q58077239	Predicting Suicidal Ideation in College Students with Mental Health Screening Questionnaires
Q88786421	Predicting Suicide Attempts and Suicide Deaths Following Outpatient Visits Using Electronic Health Records
Q36230560	Predicting Suicide Risk in Trauma Exposed Veterans: The Role of Health Promoting Behaviors
Q93172519	Predicting future self-harm or suicide in adolescents: a systematic review of risk assessment scales/tools
Q60472589	Prediction of major depressive disorder onset in college students
Q38814155	Prediction of suicidal behavior in high risk psychiatric patients using an assessment of acute suicidal state: The suicide crisis inventory
Q38823699	Predictive Validity of the Columbia-Suicide Severity Rating Scale for Short-Term Suicidal Behavior: A Danish Study of Adolescents at a High Risk of Suicide.
Q34712992	Predictive Value of Baseline Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Research Participation.
Q56977369	Predictive utility of an emergency department decision support tool in patients with active suicidal ideation
Q46000175	Predictive validity and correlates of self-assessed resilience among U.S. Army soldiers.
Q37500559	Predictive validity of the Suicide Trigger Scale (STS-3) for post-discharge suicide attempt in high-risk psychiatric inpatients
Q37373667	Predictors of Suicide Attempts in Clinically Depressed Korean Adolescents.
Q38360958	Predictors of suicidality in bariatric surgery candidates
Q37280384	Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO
Q57190989	Preliminary evidence of an association between increased cortical inhibition and reduced suicidal ideation in adolescents treated for major depression
Q35780920	Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program
Q60912478	Prevalence and correlates of psychological distress among 13-14 year old adolescent girls in North Karnataka, South India: a cross-sectional study
Q37420595	Prevalence and correlates of suicidal behavior among new soldiers in the U.S. Army: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q33908996	Prevalence and correlates of suicidal behavior among soldiers: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q24187539	Primary prevention of suicide and suicidal behaviour for adolescents in school settings
Q94400940	Primary prevention of suicide and suicidal behaviour for adolescents in school settings
Q46892853	Prior Mental Disorders and Lifetime Suicidal Behaviors Among US Army Soldiers in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q39404514	Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial
Q47409005	Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence
Q47738011	Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD.
Q34712908	Prospective assessment of suicidal ideation and behavior: an internet survey of pharmaceutical sponsor practices.
Q91263851	Prospective associations of perceived unit cohesion with postdeployment mental health outcomes
Q37445674	Prospective longitudinal evaluation of the effect of deployment-acquired traumatic brain injury on posttraumatic stress and related disorders: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q36861122	Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
Q46492974	Prospective risk factors for post-deployment heavy drinking and alcohol or substance use disorder among US Army soldiers.
Q57025000	Protocol for a prospective multicentre registry cohort study on suicide attempters given the assertive case management intervention after admission to an emergency department in Japan: post-ACTION-J Study (PACS)
Q90019164	Proximal Correlates of Suicidal Ideation and Behaviors: A Test of the Interpersonal-Psychological Theory of Suicide
Q47770284	Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders
Q39314628	Psychiatric consultations and therapy recommendations following a suicide attempt in a general hospital and their associations with selected parameters in a 1-year period
Q45326190	Psychological Inflexibility Predicts of Suicidal Ideation Over Time in Veterans of the Conflicts in Iraq and Afghanistan
Q38684179	Psychological autopsy study comparing suicide decedents, suicide ideators, and propensity score matched controls: results from the study to assess risk and resilience in service members (Army STARRS).
Q34303518	Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD
Q53409152	Psychometric validation of the Columbia-Suicide Severity rating scale in Spanish-speaking adolescents.
Q87634796	Psychopharmacologic Management of Anxiety in an Adolescent with Congenital Long QT Syndrome
Q53449717	Psychosocial health and suicidal ideation among people living with HIV/AIDS: A cross-sectional study in Nanjing, China.
Q89514316	Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study
Q52714704	Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.
Q93002897	Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Q35087455	Randomized control trial of computer-based rehabilitation of spatial neglect syndrome: the RESPONSE trial protocol
Q35681886	Randomized controlled trial of computer-based treatment of social cognition in schizophrenia: the TRuSST trial protocol
Q37420136	Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain
Q37390749	Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia
Q94379686	Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia - A Reference Guide
Q35142638	Reducing suicidal thoughts in the Australian general population through web-based self-help: study protocol for a randomized controlled trial
Q34672429	Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study
Q58757402	Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
Q35643277	Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety
Q91190920	Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
Q92240399	Relationship Between Pain Alleviation and Disease-specific Health-related Quality of Life Measures in Patients With Chronic Low Back Pain Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study
Q94452853	Relationship between Matrix Metalloproteinase-9 and Lifetime History of Suicidal Behavior in Remitted Patients with Bipolar I Disorder: A Cross-Sectional Pilot Study
Q36215160	Reliability, validity and factorial structure of the Arabic version of the international suicide prevention trial (InterSePT) scale for suicidal thinking in schizophrenia patients in Doha, Qatar
Q47821477	Religion, Sexual Orientation, and Suicide Attempts Among a Sample of Suicidal Adolescents.
Q45325642	Religious Coping and Suicide Risk in a Sample of Recently Returned Veterans
Q41597833	Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial.
Q47876948	Research with Older Adult Methadone Clients: The Importance of Monitoring Suicide Ideation
Q36096919	Research with adolescents who engage in non-suicidal self-injury: ethical considerations and challenges
Q57028551	Resting-State Functional Connectivity of the Habenula in Mood Disorder Patients With and Without Suicide-Related Behaviors
Q89689767	Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study
Q38827348	Risk Factors Proximate to Suicide and Suicide Risk Assessment in the Context of Denied Suicide Ideation
Q37329389	Risk assessment and psychosocial interventions for suicidal patients
Q38206250	Risk factors and study designs used in research of youths' suicide behaviour-an epidemiological discussion with focus on level of evidence
Q52660966	Risk factors for the transition from suicide ideation to suicide attempt: Results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).
Q36808672	Risk of suicide after a concussion
Q37193951	Risk of suicide attempt and suicide death following completion of the Patient Health Questionnaire depression module in community practice
Q35200221	Risk-sensitive decision-making deficit in adolescent suicide attempters
Q64247131	SAFETEL randomised controlled feasibility trial of a safety planning intervention with follow-up telephone contact to reduce suicidal behaviour: study protocol
Q92139777	SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies
Q38816444	SELF-RATED EXPECTATIONS OF SUICIDAL BEHAVIOR PREDICT FUTURE SUICIDE ATTEMPTS AMONG ADOLESCENT AND YOUNG ADULT PSYCHIATRIC EMERGENCY PATIENTS.
Q47644292	SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study
Q34579187	SIAM (Suicide intervention assisted by messages): the development of a post-acute crisis text messaging outreach for suicide prevention
Q100736090	Safety and Effectiveness of Lurasidone in Adolescents with Schizophrenia: Results of a 2-Year, Open-Label Extension Study
Q91701647	Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial
Q39152262	Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial).
Q67228612	Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Q42706199	Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
Q38686408	Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies
Q33632399	Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder
Q35616778	Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
Q37177212	Safety and tolerability of levomilnacipran ER in major depressive disorder: results from an open-label, 48-week extension study
Q92735072	Safety and tolerability of monthly galcanezumab injections in patients with migraine: integrated results from migraine clinical studies
Q90180716	Safety and tolerability of ubrogepant following intermittent, high-frequency dosing: Randomized, placebo-controlled trial in healthy adults
Q45062996	Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea
Q40515321	Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies
Q34451729	Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
Q37187450	Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study
Q40766078	Screening for adolescent suicidality in primary care: the bullying-insomnia-tobacco-stress test. A population-based pilot study
Q35017983	Screening for sexual orientation in psychiatric emergency departments
Q48516754	Screening for suicidal ideation and attempts among emergency department medical patients: instrument and results from the Psychiatric Emergency Research Collaboration
Q39000304	Screening to Identify Groups of Pediatric Emergency Department Patients Using Latent Class Analysis of Reported Suicidal Ideation and Behavior and Non-Suicidal Self-Injury
Q47322500	Self-Rated Depression Severity Relative to Clinician-Rated Depression Severity: Trait Stability and Potential Role in Familial Transmission of Suicidal Behavior
Q90335708	Self-Reported Suicidal Ideation as a Predictor of Suicidal Behavior Among Outpatients With Diagnoses of Psychotic Disorders
Q41103337	Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
Q48037241	Serious Suicide Attempts
Q64085804	Service Use History of Individuals Enrolling in a Web-Based Suicidal Ideation Treatment Trial: Analysis of Baseline Data
Q57052828	Short term risk of non-fatal and fatal suicidal behaviours: the predictive validity of the Columbia-Suicide Severity Rating Scale in a Swedish adult psychiatric population with a recent episode of self-harm
Q47140935	Significant Need for a French Network of Expert Centers Enabling a Better Characterization and Management of Treatment-Resistant Depression (Fondation FondaMental).
Q34713001	Simple Measures of Hopelessness and Impulsivity are Associated with Acute Suicidal Ideation and Attempts in Patients in Psychiatric Crisis.
Q91411481	Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression
Q92569078	Single- and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 Studies
Q35819300	Single-Item Measurement of Suicidal Behaviors: Validity and Consequences of Misclassification
Q37394653	Sleep Complaints as Risk Factor for Suicidal Behavior in Severely Depressed Children and Adolescents
Q47219121	Sleep complaints associated with wish to die after a suicide crisis-an exploratory study
Q38614134	Social and psychological contributions to the co-occurrence of sub-threshold psychotic experiences and suicidal behavior.
Q91647507	Social cognition and short-term prediction of suicidal ideation in schizophrenia
Q30845248	Socio-neuro risk factors for suicidal behavior in criminal offenders with psychotic disorders
Q90308338	Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial
Q38845308	Startle amplitude during unpleasant pictures is greater in veterans with a history of multiple-suicide attempts and predicts a future suicide attempt.
Q34713076	Status Update on the Sheehan-Suicidality Tracking Scale (S-STS) 2014
Q90242244	Study protocol of a multicenter randomized controlled trial of mindfulness-based intervention versus relaxation to reduce emotional exhaustion in medical students in France: the "Must prevent" study
Q58799451	Study protocol: a cluster-randomized trial implementing Sustained Patient-centered Alcohol-related Care (SPARC trial)
Q35572332	Suicidal Behavior Outcomes of Childhood Sexual Abuse: Longitudinal Study of Adjudicated Girls
Q47274439	Suicidal Behavior and Non-Suicidal Self-Injury in Emergency Departments Underestimated by Administrative Claims Data
Q39678714	Suicidal Ideation After Mild Traumatic Brain Injury: A Consecutive Canadian Sample
Q90592767	Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease
Q61804874	Suicidal Ideation Predicts Functioning and Quality of Life Over One Year after Acute Coronary Syndrome
Q52627071	Suicidal Thoughts and Behaviors Among First-Year College Students: Results From the WMH-ICS Project.
Q33915477	Suicidal behavior disorder as a diagnostic entity in the DSM-5 classification system: advantages outweigh limitations
Q47972742	Suicidal behaviors in adolescents with ADHD: associations with depressive and other comorbidity, parent-child conflict, trauma exposure, and impairment.
Q42689695	Suicidal ideation and behavior assessment in dementia studies: An Internet survey
Q92746028	Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials
Q45347888	Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials
Q39091505	Suicidal ideation and subsequent completed suicide in both psychiatric and non-psychiatric populations: a meta-analysis.
Q37715480	Suicidal ideation and suicidal behaviour in delusional disorder: a clinical overview.
Q37079955	Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions
Q40139723	Suicidal ideation in elderly Korean population: a two-year longitudinal study
Q90896248	Suicidal ideation is common in autosomal dominant Alzheimer's disease at-risk persons
Q37283094	Suicidal ideation of psychiatrically hospitalized adolescents has one-year predictive validity for suicide attempts in girls only
Q64105646	Suicidal ideation, suicidal behaviors, and attitudes towards suicide of adolescents enrolled in the Alternative Learning System in Manila, Philippines-a mixed methods study
Q37123096	Suicidal ideation, suicide attempt, and occupations among employed adults aged 18-64years in the United States
Q92665647	Suicidal risk and executive functions in major depressive disorder: a study protocol
Q38385197	Suicidal tendencies as correlates of disability measures
Q24612175	Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine
Q90701700	Suicidality Disparities Between Transgender and Cisgender Adolescents
Q27009981	Suicidality associated with antiepileptic drugs: implications for the treatment of neuropathic pain and fibromyalgia
Q38858557	Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies
Q47729064	Suicide Crisis Syndrome Mediates the Relationship Between Long-term Risk Factors and Lifetime Suicidal Phenomena
Q60144036	Suicide Ideation in Adolescents Following Inpatient Hospitalization: Examination of Intensity and Lability Over 6 Months
Q36126962	Suicide Ideations, Suicide Attempts, and Completed Suicide in Persons with Pathological Gambling and Their First-Degree Relatives
Q47276323	Suicide Prevention in Correctional Settings: Current Standards and Recommendations for Research, Prevention, and Training
Q38813098	Suicide Prevention in an Emergency Department Population: The ED-SAFE Study
Q39305044	Suicide Risk Assessment in Adolescents - C-SSRS, K10, and READ.
Q36499711	Suicide Risk Associated with Experience of Violence and Impulsivity in Alcohol Dependent Patients
Q99589239	Suicide Risk Management Protocol for a Randomized Controlled Trial of Cardiac Patients Reporting Hopelessness
Q47843118	Suicide Risk Screening in Healthcare Settings: Identifying Males and Females at Risk.
Q58552680	Suicide Risk Screening in Pediatric Hospitals: Clinical Pathways to Address a Global Health Crisis
Q47189567	Suicide Risk across Latent Class Subgroups: A Test of the Generalizability of the Interpersonal Psychological Theory of Suicide.
Q34494779	Suicide and suicidal behaviour
Q36096184	Suicide attempt risk in youths: utility of the Harkavy-Asnis suicide scale for monitoring risk levels
Q36952424	Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials
Q41760947	Suicide risk assessment: tools and challenges
Q42329563	Suicide risk characteristics among aborted, interrupted, and actual suicide attempters
Q34063792	Suicide risk in primary care: identification and management in older adults
Q36296763	Suicide risk in youth with intellectual disabilities: the challenges of screening
Q43454570	Suicides among military conscripts between 1991-2007 in Finland--a descriptive replication study
Q31113697	Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials
Q52561628	Symptom severity and its clinical correlates in kleptomania.
Q37123114	Symptoms of posttraumatic stress, depression, and anxiety as predictors of suicidal ideation among South African university students
Q40952954	Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials
Q35136799	Teen options for change: an intervention for young emergency patients who screen positive for suicide risk
Q36003863	Testing the efficacy of a brief sexual risk reduction intervention among high-risk American Indian adults: study protocol for a randomized controlled trial
Q28262669	The ABC's of Suicide Risk Assessment: Applying a Tripartite Approach to Individual Evaluations
Q64901890	The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease.
Q63874557	The Brief Death Implicit Association Test: Scoring recommendations, reliability, validity, and comparisons with the Death Implicit Association Test
Q34713048	The Columbia-Suicide Severity Rating Scale (C-SSRS): Has the "Gold Standard" Become a Liability?
Q48040359	The Double-Edged Sword - Outward and Inward Directed Aggression among War Combatants
Q31140348	The EVIDENT-trial: protocol and rationale of a multicenter randomized controlled trial testing the effectiveness of an online-based psychological intervention
Q90751456	The Effect of Octanoic Acid on Essential Voice Tremor: A Double-Blind, Placebo-Controlled Study
Q37691481	The Emergency Department Safety Assessment and Follow-up Evaluation (ED-SAFE): method and design considerations
Q45326783	The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders
Q36731061	The Influence of Anxiety Sensitivity on a Wish to Die in Complicated Grief
Q57170418	The Link between Posttraumatic Stress Disorder and Functionality among United States Military Service Members Psychiatrically Hospitalized Following a Suicide Crisis
Q93011453	The Ohio State University Early Psychosis Intervention Center (EPICENTER) step-based care programme for individuals at clinical high risk for psychosis: study protocol for an observational study
Q48063121	The Patient Safety Screener: Validation of a Brief Suicide Risk Screener for Emergency Department Settings
Q93360418	The Relationship Between Intimate Partner Violence and Suicidal Ideation among Young Chinese, Korean, and Vietnamese American Women
Q93336842	The Role of Personal Factors and Learning Environment in Suicidal Ideation Among Tunisian Medical Students
Q90293050	The Role of Psychological and Social Factors in the Relationship between Attachment and Suicide: A Systematic Review
Q44017233	The Specificity of the Interpersonal-Psychological Theory of Suicidal Behavior for Identifying Suicidal Ideation in an Online Sample.
Q48008454	The Suicide Narrative Interview: adolescents' attachment expectancies and symptom severity in a clinical sample
Q47804974	The Time Course of Effect of Multilayer-Release Methylphenidate Hydrochloride Capsules: A Randomized, Double-Blind Study of Adults With ADHD in a Simulated Adult Workplace Environment
Q42602719	The Twenty-Year Trajectory of Suicidal Activity Among Post-Hospital Psychiatric Men and Women with Mood Disorders and Schizophrenia
Q52661739	The Zero Suicide Model: Applying Evidence-Based Suicide Prevention Practices to Clinical Care.
Q92350285	The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial
Q34504812	The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial
Q41869167	The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
Q37309552	The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study
Q39274916	The effect of perceived burdensomeness and thwarted belongingness on therapists' assessment of patients' suicide risk
Q89720555	The efficacy of Narrative Exposure Therapy for Children (KIDNET) as a treatment for traumatized young refugees versus treatment as usual: study protocol for a multi-center randomized controlled trial (YOURTREAT)
Q35954635	The efficacy of a new translational treatment for persecutory delusions: study protocol for a randomised controlled trial (The Feeling Safe Study).
Q39759446	The experience of depression, anxiety, and mania among perinatal women
Q34621586	The impact of losing a child on the clinical presentation of complicated grief
Q37141463	The impact of posttraumatic stress disorder on the symptomatology of borderline personality disorder
Q89792774	The interRAI Suite of Mental Health Assessment Instruments: An Integrated System for the Continuum of Care
Q45326556	The loss of a fellow service member: Complicated grief in post-9/11 service members and veterans with combat-related posttraumatic stress disorder.
Q48086936	The patient safety screener: validation of a brief suicide risk screener for emergency department settings
Q64107311	The prediction of suicide in severe mental illness: development and validation of a clinical prediction rule (OxMIS)
Q91936522	The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder
Q38222199	The risk of suicide mortality in chronic pain patients
Q38587327	The role of quantitative safety evaluation in regulatory decision making of drugs.
Q57159611	The role of substance use, smoking, and inflammation in risk for suicidal behavior
Q38610490	The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
Q45401612	The self-directed violence classification system and the columbia classification algorithm for suicide assessment: a crosswalk
Q33744415	The statistics of suicide
Q89450516	The subjective perception of the association between psychotic experiences and suicidal behavior among young adults
Q48338347	The suicidal ideation attributes scale (SIDAS): Community-based validation study of a new scale for the measurement of suicidal ideation
Q39740632	The use of varenicline to treat nicotine dependence among patients with cancer.
Q34531316	The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study
Q104739489	Thirty-day suicidal thoughts and behaviors among hospital workers during the first wave of the Spain COVID-19 outbreak
Q58716286	Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies
Q49916895	Tolerance for psychological pain and capability for suicide: Contributions to suicidal ideation and behavior
Q38283441	Tourette syndrome deep brain stimulation: a review and updated recommendations
Q47658997	Toward mHealth Brief Contact Interventions in Suicide Prevention: Case Series From the Suicide Intervention Assisted by Messages (SIAM) Randomized Controlled Trial.
Q38885573	Towards understanding and predicting suicidality in women: biomarkers and clinical risk assessment
Q38233601	Training for suicide risk assessment and suicide risk formulation
Q47932522	Trajectories of Suicidal Ideation among Adolescents Following Psychiatric Hospitalization
Q92075700	Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder
Q53280931	Treating prolonged grief disorder with prolonged grief-specific cognitive behavioral therapy: study protocol for a randomized controlled trial.
Q38828355	Treatment Options for Narcolepsy
Q30361078	Treatment moderators of child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder.
Q37713091	Treatment of Major Depressive Disorder with Iyengar Yoga and Coherent Breathing: A Randomized Controlled Dosing Study
Q47100237	Treatment of Major Depressive Disorder with Iyengar Yoga and Coherent Breathing: A Randomized Controlled Dosing Study
Q38884124	Treatment of Nightmares in Psychiatric Inpatients With Imagery Rehearsal Therapy: An Open Trial and Case Series
Q38423260	Treatment of complicated grief in elderly persons: a randomized clinical trial
Q99408010	Treatments for Self-Injurious Thoughts and Behaviors in Youth: Progress and Challenges
Q46280394	Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease
Q60620701	Trustworthiness appraisal deficits in borderline personality disorder are associated with prefrontal cortex, not amygdala, impairment.
Q47551793	Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample.
Q92912913	U-Flourish university students well-being and academic success longitudinal study: a study protocol
Q90231600	Uncharted Waters: Treating Trauma Symptoms in the Context of Early Psychosis
Q37700028	Understanding Depressive Symptoms and Psychosocial Stressors on Twitter: A Corpus-Based Study
Q36594563	Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach
Q44117372	Understanding linkages between bullying and suicidal ideation in a national sample of LGB and heterosexual youth in the United States
Q34443430	Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review
Q92511530	Understanding the impact of complicated grief on combat related posttraumatic stress disorder, guilt, suicide, and functional impairment in a clinical trial of post-9/11 service members and veterans
Q96228352	Unit cohesion during deployment and post-deployment mental health: is cohesion an individual- or unit-level buffer for combat-exposed soldiers?
Q47779584	Universal Adolescent Suicide Screening in a Pediatric Urgent Care Center
Q38407027	Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole
Q38672850	Use of the Columbia-Suicide Severity Rating Scale (C-SSRS) to Classify Suicidal Behaviors
Q34129556	Using structured telephone follow-up assessments to improve suicide-related adverse event detection
Q33830618	Utility of a time frame in assessing psychological pain and suicide ideation
Q47874233	Validation of rapid suicidality screening in epilepsy using the NDDIE.
Q92454196	Validation of the InnoWell Platform: Protocol for a Clinical Trial
Q93029527	Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDIE) as a rapid suicidality screening tool in Chinese people with epilepsy
Q90715297	Validity of the WHIPLASHED as a tool to identify bipolar disorder in women
Q34992065	Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial
Q92539742	Variation in patterns of health care before suicide: A population case-control study
Q38635826	Variations of emotion dysregulation in borderline personality disorder: a latent profile analysis approach with adult psychiatric inpatients
Q52613387	Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trials.
Q34672417	Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study
Q55647096	Web-based intervention to improve quality of life in late stage bipolar disorder (ORBIT): randomised controlled trial protocol.
Q64954037	Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
Q37138425	What goes up must come down: the burden of bipolar depression in youth
Q89456737	When does grief become pathological? Evaluation of the ICD-11 diagnostic proposal for prolonged grief in a treatment-seeking sample
Q35691130	Widespread white matter but focal gray matter alterations in depressed individuals with thoughts of death
Q37707284	Young adult follow-up of adolescent girls in juvenile justice using the Columbia suicide severity rating scale.
Q64259402	Young migrant mental health difficulties and suicidal behaviours: an alternative perspective
Q48071032	Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin.
Q89432159	Youth at-risk for serious mental illness: methods of the PROCAN study
Q48231913	Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.

P356	DOI	10.1176/APPI.AJP.2011.10111704
P932	PMC publication ID	3893686
P698	PubMed publication ID	22193671
P5875	ResearchGate publication ID	51919844

P50	author	David A Brent	Q92666622
		Laurence L Greenhill	Q109420186
		Kelly Posner	Q114314406
		Glenn A. Melvin	Q43703917
		Barbara Stanley	Q67225040
		Maria A Oquendo	Q76003719
P2093	author name string	J John Mann
		Glenn W Currier
		Sa Shen
		Gregory K Brown
		Kseniya V Yershova
P2860	cites work	Worst-point suicidal plans: a dimension of suicidality predictive of past suicide attempts and eventual death by suicide	Q79218979
		Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability	Q24632459
		Assessment of suicidal intention: The Scale for Suicide Ideation	Q28244530
		Classification of suicidal behaviors: I. Quantifying intent and medical lethality	Q33335272
		The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step	Q33851855
		Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study	Q33927808
		The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial	Q33940277
		Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology	Q34121132
		The internal struggle between the wish to die and the wish to live: a risk factor for suicide	Q34456093
		A current perspective of suicide and attempted suicide	Q34534227
		Comparison of clinical and research assessments of diagnosis, suicide attempt history and suicidal ideation in major depression	Q37202157
		Impulsive and non-impulsive suicide attempts in patients treated for alcohol dependence	Q37243042
		Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants	Q37246423
		Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement	Q37783373
		Assessment of suicide risk	Q39668763
		Rethinking impulsivity in suicide	Q39797666
		Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients	Q40919861
		Eventual suicide in interrupted and uninterrupted attempters: a challenge to the cry-for-help hypothesis	Q41441878
		Characteristics of impulsive suicide attempts and attempters	Q43940819
		The prevalence of aborted suicide attempts among psychiatric in-patients	Q44021536
		Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial	Q44091924
		Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey	Q45189352
		Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.	Q45998548
		Factor structure and psychometric properties of the Modified Scale for Suicidal Ideation among suicidal youth	Q47335526
		Risk factors for suicide in psychiatric outpatients: a 20-year prospective study	Q47347756
		Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients	Q47348755
		Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients	Q47349759
		"Impulsive" youth suicide attempters are not necessarily all that impulsive	Q48385822
		Behind impulsive suicide attempts: indications from a community study	Q48407295
		Toward a clinical model of suicidal behavior in psychiatric patients.	Q50532711
		Prevalence of and risk factors for suicide attempts versus suicide gestures: analysis of the National Comorbidity Survey.	Q51914408
		Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included.	Q51943471
		Incidence of suicide ideation and attempts in adults: the 13-year follow-up of a community sample in Baltimore, Maryland.	Q51962383
		Incidence and predictors of suicidal behaviors in a longitudinal sample of young adolescents.	Q51993477
		Suicidal feelings in the general population: a prevalence study.	Q54339713
		Survival analysis of suicide risk after attempted suicide	Q60641122
		Neurobiology of suicidal behaviour	Q79108279
P433	issue	12
P407	language of work or name	English	Q1860
P921	main subject	suicide	Q10737
		teenager	Q1492760
P304	page(s)	1266-1277
P577	publication date	2011-12-01
P1433	published in	American Journal of Psychiatry	Q1935368
P1476	title	The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults
P478	volume	168

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

scientific article

Reverse relations